Calidi Biotherapeutics, Inc. (CLDI)

R&D Expenses

$9.86M

TTM · Period ending: · USD

CLDI logo

CLDI R&D Expenses

Latest reported$9.86M
CLDI TTM R&D Expenses ($2.81M → $9.86M)
High-resolution chart · PNG

CLDI r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Calidi Biotherapeutics, Inc. R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
9,864,000
9,899,000
9,737,000
9,194,000
8,986,000
8,560,000
8,878,000
11,021,000
12,119,000
13,129,000
13,008,000
11,313,000
10,007,000
8,314,000
7,257,000
6,240,000
4,295,000
2,811,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.